Ebb® with PrecisionCool™ Technology targets the #1 cause of sleeplessness, a Racing Mind. No drugs. No side effects. Just your most satisfying sleep.
Location: United States, Pennsylvania, Pittsburgh
Employees: 11-50
Phone: +1 800-381-1145
Total raised: $38M
Founded date: 2008
Investors 3
| Date | Name | Website |
| - | University... | innovation... |
| - | Partner Ve... | partnervc.... |
| - | Kohlberg K... | kkr.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.01.2017 | Series B | $38M | - |
Mentions in press and media 5
| Date | Title | Description |
| 15.12.2020 | ChiliSleep’s parent company raises $37M and merges with Ebb Therapeutics | Kryo, the company behind the ChiliSleep brand, is announcing that it has merged with another sleep technology company, Ebb Therapeutics, and also raised $37 million in new funding led by Ebb’s biggest investor, KKR. Founded in 2007, Kryo/Ch... |
| 05.01.2017 | Cerêve Raises $38 Million to Fuel Launch of Insomnia Device in New Financing Led by KKR | Investment Will Fund Launch of FDA-cleared Device to Safely Treat Insomnia OAKMONT, Pa.--(BUSINESS WIRE)-- Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing o... |
| 05.01.2017 | KKR Leads $38 Million Series B for Cerêve | OAKMONT, Pa.--(BUSINESS WIRE)--Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing led by KKR, a leading global inve... |
| 05.01.2017 | Cerêve Closes $38M Series B Financing | Cerêve Inc., an Oakmont, PA-based healthcare company preparing to launch an FDA-cleared insomnia device, closed a $38m Series B round of financing. The round was led by KKR, with participation from existing shareholders Versant Ventures, Ar... |
| 05.01.2017 | Cerêve Raises $38 Million Series B | OAKMONT, Pa.--(BUSINESS WIRE)--Cerêve Inc., a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing led by KKR, a leading global inve... |